相关实验视频

Updated: Jan 12, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

抗ALDOA抗体:一种新型诊断相关的抗体,用于肌痛性骨髓灰质炎

Mengdi Zhang¹, Yingna Zhang¹, Peipei Liu¹

¹Department of Neuroimmunology, Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.

Frontiers in neurology

|November 7, 2025

概括

研究人员发现阿尔多酶A (ALDOA) 是一种新型的自身抗原,用于血清阴性肌痛性肌痛性肌痛症 (SNMG). 反ALDOA抗体显示MG的诊断潜力,即使在阳性病例中也是如此.

科学领域:

免疫学免疫学免疫学
神经学神经学
生物化学生物化学

背景情况:

骨髓灰质炎 (MG) 是一种影响神经肌肉结合的自身免疫性疾病.
血清阴性MG (SNMG) 缺乏针对乙胆受体 (AChR) 或肌肉特异性激酶 (MuSK) 的可检测抗体.
识别新型自身抗原对于SNMG诊断和了解病原体至关重要.

研究的目的:

在SNMG患者中识别新型自身抗体.
描述已识别的自身抗原及其相关抗体.
评估这些抗体在MG亚型中的诊断效用.

主要方法:

使用有针对性的结合试验 (TBA) 对SNMG血清的查.
免疫沉和质谱测量用于抗原识别.
在676名MG患者和20个对照群中,用于验证和基于细胞的测定 (CBA) 检测抗体的西部涂抹.

主要成果:

阿尔多酶A (ALDOA) 被确定为一种新型自身抗原.
反ALDOA抗体 (ALDOA-Ab) 在SNMG中显示出高的诊断特异性.
在4.89%的ACHR-Ab+ MG和2.86%的MuSK-Ab+ MG患者中检测到ALDOA-Ab,主要是IgG1亚类.

结论:

阿尔多阿是一种与MG相关的新型自身抗原.
反ALDOA抗体代表了MG的潜在诊断生物标志物,包括血清阴性和血清阳性形式.
需要进一步的研究来阐明ALDOA-Ab在MG中的致病作用.

关键词:

自动抗体是一种自身抗体.临床诊断临床诊断临床诊断蛋白质组学蛋白质组学血清消极的严重肌痛性肌痛症.基于组织的测定.

更多相关视频

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...